NHS Framework for the Midlands and East, Branded Medicines – Tranche B

Offer reference number: CM/PHR/16/5524

Period of framework agreement:

CM/PHR/16/5524 /01 – NHS Framework for the Midlands and East, Branded Medicines – Tranche B – 1.3.2019 to 28.2.2021 with an option to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months

CM/PHR/16/5524 /02 – NHS Framework for the Midlands and East, Branded Medicines – Tranche B (Cytokine modulators and other monoclonal antibodies) – 1.3.2019 to 29.2.2020 with an option to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months

The Framework is intended for use by the Department of Health and Social Care, Public Health England and the NHS in England. The Framework may also be used by private sector contractors and agents working on behalf of the above.

Products associated with the lots are listed on Document No 05 of the Invitation to Offer.

Each individual National Product Code (NPC) pack description in each of the regions (Midlands and East of England) is deemed to be a separate product for the application of the award criteria.

There is no restriction on the number of products that bidders can offer for, or be awarded.

The framework agreement is intended for use by the Department of Health, Public Health England and the NHS in England.

The framework may also be used by private sector contractors and agents working on behalf of the above.